Analysis and Commentary STEVEN GROSSMAN 9/28/18 Analysis and Commentary STEVEN GROSSMAN 9/28/18 Janet Woodcock on CDER's Needs and Opportunities Read More Advocacy at a Glance STEVEN GROSSMAN 9/28/18 Advocacy at a Glance STEVEN GROSSMAN 9/28/18 FDA Appropriations in Limbo and more Read More Analysis and Commentary STEVEN GROSSMAN 9/21/18 Analysis and Commentary STEVEN GROSSMAN 9/21/18 Positive Thoughts on an Imperiled Four-Bill Minibus Read More Advocacy at a Glance STEVEN GROSSMAN 9/21/18 Advocacy at a Glance STEVEN GROSSMAN 9/21/18 FY 19 Ag/FDA Appropriations: Still Possible Before October 1 and more Read More Analysis and Commentary STEVEN GROSSMAN 9/14/18 Analysis and Commentary STEVEN GROSSMAN 9/14/18 Three Possible Ways to Hatch an Egg Read More Advocacy at a Glance STEVEN GROSSMAN 9/14/18 Advocacy at a Glance STEVEN GROSSMAN 9/14/18 Appropriations Situation Clarifying; Fate of Ag/FDA Unresolved Read More STEVEN GROSSMAN 9/7/18 STEVEN GROSSMAN 9/7/18 Timing, Knowns, and Unknowns: FDA's FY 19 Appropriation Read More Advocacy at a Glance STEVEN GROSSMAN 9/7/18 Advocacy at a Glance STEVEN GROSSMAN 9/7/18 Congress Returns; Appropriations Bills Advance and more Read More Analysis and Commentary STEVEN GROSSMAN 8/31/18 Analysis and Commentary STEVEN GROSSMAN 8/31/18 On the Physical Capabilities of a Lame Duck Read More Advocacy at a Glance STEVEN GROSSMAN 8/31/18 Advocacy at a Glance STEVEN GROSSMAN 8/31/18 Senate Changes in 302(b) Allocations? Read More Analysis and Commentary STEVEN GROSSMAN 8/24/18 Analysis and Commentary STEVEN GROSSMAN 8/24/18 August as Usual in DC? Definitively NOT! Read More Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Senate Finishes Consideration of DoD/Labor-HHS Mini-bus Funding Bill and more Read More Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Sometimes There Really Is a Win-Win Read More Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Ag/FDA Moves in the Senate Read More Analysis and Commentary STEVEN GROSSMAN 8/5/18 Analysis and Commentary STEVEN GROSSMAN 8/5/18 The Full Senate Position on FDA's FY 19 Appropriation Read More Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Senate Passes FY 19 Ag/FDA Funding as Part of 4-bill Mini-bus Read More Advocacy at a Glance STEVEN GROSSMAN 7/27/18 Advocacy at a Glance STEVEN GROSSMAN 7/27/18 FDA's Appropriation for FY 19: Upsides and Downsides Read More Advocacy at a Glance STEVEN GROSSMAN 7/27/18 Advocacy at a Glance STEVEN GROSSMAN 7/27/18 Senate Starts, Doesn’t Finish, Mini-bus Including Ag/FDA Read More STEVEN GROSSMAN 7/24/18 STEVEN GROSSMAN 7/24/18 “First, do no harm” Read More Advocacy at a Glance STEVEN GROSSMAN 7/24/18 Advocacy at a Glance STEVEN GROSSMAN 7/24/18 Ag/FDA Likely in September Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 9/28/18 Analysis and Commentary STEVEN GROSSMAN 9/28/18 Janet Woodcock on CDER's Needs and Opportunities Read More
Advocacy at a Glance STEVEN GROSSMAN 9/28/18 Advocacy at a Glance STEVEN GROSSMAN 9/28/18 FDA Appropriations in Limbo and more Read More
Analysis and Commentary STEVEN GROSSMAN 9/21/18 Analysis and Commentary STEVEN GROSSMAN 9/21/18 Positive Thoughts on an Imperiled Four-Bill Minibus Read More
Advocacy at a Glance STEVEN GROSSMAN 9/21/18 Advocacy at a Glance STEVEN GROSSMAN 9/21/18 FY 19 Ag/FDA Appropriations: Still Possible Before October 1 and more Read More
Analysis and Commentary STEVEN GROSSMAN 9/14/18 Analysis and Commentary STEVEN GROSSMAN 9/14/18 Three Possible Ways to Hatch an Egg Read More
Advocacy at a Glance STEVEN GROSSMAN 9/14/18 Advocacy at a Glance STEVEN GROSSMAN 9/14/18 Appropriations Situation Clarifying; Fate of Ag/FDA Unresolved Read More
STEVEN GROSSMAN 9/7/18 STEVEN GROSSMAN 9/7/18 Timing, Knowns, and Unknowns: FDA's FY 19 Appropriation Read More
Advocacy at a Glance STEVEN GROSSMAN 9/7/18 Advocacy at a Glance STEVEN GROSSMAN 9/7/18 Congress Returns; Appropriations Bills Advance and more Read More
Analysis and Commentary STEVEN GROSSMAN 8/31/18 Analysis and Commentary STEVEN GROSSMAN 8/31/18 On the Physical Capabilities of a Lame Duck Read More
Advocacy at a Glance STEVEN GROSSMAN 8/31/18 Advocacy at a Glance STEVEN GROSSMAN 8/31/18 Senate Changes in 302(b) Allocations? Read More
Analysis and Commentary STEVEN GROSSMAN 8/24/18 Analysis and Commentary STEVEN GROSSMAN 8/24/18 August as Usual in DC? Definitively NOT! Read More
Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Senate Finishes Consideration of DoD/Labor-HHS Mini-bus Funding Bill and more Read More
Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Sometimes There Really Is a Win-Win Read More
Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Ag/FDA Moves in the Senate Read More
Analysis and Commentary STEVEN GROSSMAN 8/5/18 Analysis and Commentary STEVEN GROSSMAN 8/5/18 The Full Senate Position on FDA's FY 19 Appropriation Read More
Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Senate Passes FY 19 Ag/FDA Funding as Part of 4-bill Mini-bus Read More
Advocacy at a Glance STEVEN GROSSMAN 7/27/18 Advocacy at a Glance STEVEN GROSSMAN 7/27/18 FDA's Appropriation for FY 19: Upsides and Downsides Read More
Advocacy at a Glance STEVEN GROSSMAN 7/27/18 Advocacy at a Glance STEVEN GROSSMAN 7/27/18 Senate Starts, Doesn’t Finish, Mini-bus Including Ag/FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 7/24/18 Advocacy at a Glance STEVEN GROSSMAN 7/24/18 Ag/FDA Likely in September Read More
